The burgeoning digital marketplace has presented novel avenues for accessing prescription medications, including the stimulant Adderall, primarily recommended for attention deficit hyperactivity disorder (ADHD). While proponents of cognitive enhancement argue that these substances can improve focus and productivity, ethical concerns escalate surrou